Navigation Links
OrbusNeich's Genous™ Stent Enables Early and Safe Discontinuation of Dual Antiplatelet Therapy in High-Risk Patients Requiring Nondeferrable, Non-Cardiac Surgery
Date:7/18/2011

or these complex cases."

The study included 26 patients who underwent PCI and 20 patients then received non-cardiac surgical intervention within 60 days of the PCI. The primary outcome of the study was the occurrence of cardiac death, myocardial infarction (MI), ST and MACE. According to the American Heart Association /American College of Cardiology (AHA/ACC) guidelines, non-cardiac surgery should be delayed by four to six weeks following PCI with a bare metal stent (BMS) and one year following PCI with a drug eluting stent (DES).

About Genous  

Genous is OrbusNeich's patented EPC capture technology that promotes the accelerated natural healing of the vessel wall after the implantation of blood-contact devices such as stents. The technology consists of an antibody surface coating that attracts EPCs circulating in the blood to the device to form an endothelial layer that provides protection against thrombosis and modulates restenosis.

The Genous Stent, which has been commercially available in more than 60 countries since 2005, has been proven as a safe, effective alternative to drug eluting stents and is supported by data from more than 6,000 patients in company-sponsored clinical studies. There is a growing body of evidence from multiple clinical studies that the Genous Stent is effective for patients who are non-responsive to or cannot tolerate long-term dual antiplatelet therapy.

About OrbusNeich

OrbusNeich is a global company that designs, develops, manufactures and markets innovative medical devices for the treatment of vascular diseases. Current products are the world's first pro-healing stent, the Genous Stent, as well as other stents and balloons marketed under the names of Azule™, R stent, Scoreflex™, Sapphire™, Sapphire II and Sapphire NC. Development stage products include the Combo™ Bio-engineered Sirolimus Eluting Stent, or Combo Stent, which combines the Genous pro-hea
'/>"/>

SOURCE OrbusNeich
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Study Confirms that OrbusNeichs Genous™ Stent Effectively Captures Circulating Endothelial Progenitor Cells to Accelerate Re-Endothelialization and Decrease Thrombogenicity
2. OrbusNeichs Genous™ Stent is Safe and Effective in Cases Where Prolonged Dual Antiplatelet Therapy is Not Advisable as Presented at EuroPCR 2011
3. Data Published in the Journal of Interventional Cardiology Demonstrate Effectiveness and Safety of OrbusNeichs Genous™ Stent in Diabetic Patients
4. Published Data From e-HEALING Registry Demonstrate Good Clinical Outcomes With Low Incidence of Repeat Revascularization and Stent Thrombosis for OrbusNeichs Genous™ Stent
5. Safety and Efficacy of OrbusNeichs Genous™ Stent Demonstrated in High-Risk Patients with Known Contraindications for Dual Antiplatelet Therapy
6. OrbusNeich Granted Expanded U.S. Patent of Genous™ Endothelial Progenitor Cell Capture Technology
7. OrbusNeichs Genous™ Stent Shows Favorable Outcomes for Treatment of Coronary Artery Bifurcation Lesions Compared to Bare Metal Stents
8. Randomized Clinical Trial of OrbusNeichs Genous™ Bio-engineered R stent™ in China Completes Patient Enrollment
9. Data from Multiple Clinical Trials of OrbusNeichs Genous™ Bio-engineered R Stent™ Demonstrate Safety and Effectiveness Across Challenging Patient Subsets as Presented at TCT 2010
10. OrbusNeichs Genous™ Bio-engineered R stent™ Shows Favorable Safety Profile and Clinical Outcomes in Combination with Paclitaxel-Coated Balloon for De Novo Coronary Artery Disease
11. 100 Percent Coverage of Struts and Complete Neointimal Coverage of OrbusNeichs Genous™ Bio-engineered R stent™ Demonstrated 26 Days Post-Implantation in STEMI Patient
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... June 3, 2015 The treatment ... the market, says  GBI Research . ... - Acute Myeloid Leukemia Therapeutics Market to 2020 ... to increase moderately from $632.6 million in 2013 to $878.6 ... of 4.8%. Several drugs to treat AML are ...
(Date:6/3/2015)... Arabia , June 3, 2015  Varian Medical Systems (NYSE: ... for the treatment of cancer, is expanding in the ... operating entity in Saudi Arabia . Varian ... El Seif Development Group, was officially launched today at a ... Dow Wilson. "This move represents the next ...
(Date:6/3/2015)... , June 3, 2015   Health Data Consortium (HDC) , a ... foster collaborations using data to improve health and healthcare, ... the Director of the Office of Enterprise Data and ... (CMS), as the recipient of this year,s Health ... CMS data in innovative ways to help improve the ...
Breaking Medicine Technology:Novel Acute Myeloid Leukemia Therapies to Offer Clinical Benefit in Small Patient Cohorts 2Novel Acute Myeloid Leukemia Therapies to Offer Clinical Benefit in Small Patient Cohorts 3Varian Establishes Local Entity in Saudi Arabia to Support Expansion in Middle East 2CMS Chief Data Officer and Health Data Advocate Niall Brennan Receives Third Annual Health Data Liberators Award 2CMS Chief Data Officer and Health Data Advocate Niall Brennan Receives Third Annual Health Data Liberators Award 3CMS Chief Data Officer and Health Data Advocate Niall Brennan Receives Third Annual Health Data Liberators Award 4
... Reports on 11 Patients at SAWCPRINCETON, N.J., April 29 ... (OTC Bulletin Board: DSCI), a provider of advanced ... on the Advances in Wound Care (SAWC) in Dallas, Jason ... South Florida, revealed details of a recently concluded 11-patient venous ...
... the REDUCE trial results at the American Urological Association annual ... as dutasteride (Avodart), a drug used to treat benign prostatic ... of prostate cancer in men with an increased risk of ... an additional tool in the fight against prostate cancer. ...
Cached Medicine Technology:Clinician Reports Fast Healing of Intractable Wounds Using MEDIHONEY(R) 2Clinician Reports Fast Healing of Intractable Wounds Using MEDIHONEY(R) 3Study Results Present Paradigm Shift; REDUCE Trial Shows New Hope for the Risk Reduction of Prostate Cancer 2
(Date:6/3/2015)... 03, 2015 Acne is the same wherever ... particularly stubborn to eliminate and hard to prevent. As with ... teens and young adults, in the years when the sebaceous ... oil,” says Jayme Bashian, director and lead medical aesthetician of ... and cysts of acne are caused by oil and dead ...
(Date:6/3/2015)... These are challenging and unpredictable times ... number of digital-first business are rewriting the rules for ... serious need for traditional businesses to take on a ... deliver their services. On top of this there ... technology start-ups, to bring new innovation and approaches to ...
(Date:6/3/2015)... “ Scanalytics ” was featured on NewsWatch ... the latest and coolest technology products available to consumers. ... NewsWatch, conducted the review and shared with viewers how ... retail stores. , Tracking statistics in business is invaluable ... to retail this goes a step beyond revenue statistics ...
(Date:6/3/2015)... Foot and Ankle Specialists of the Mid-Atlantic, ... Clarksville Division ) was recently presented with the Wound ... Care (SAWC) and the American Podiatric Medical Association (APMA), ... Conference was held on April 29-May 3, 2015, at ... TX. , Dr. Casey Friske graduated from Indiana ...
(Date:6/3/2015)... Unfortunately, a majority of shoes sold are not up ... the users throughout the year. Be it a pair of ... market, the makers generally tend to put all of their ... comfort and health. To counter this problem and provide a ... Vay Technologies have come up with uGALE, an insole that ...
Breaking Medicine News(10 mins):Health News:Back Acne: Tips for Clearer Summer Skin 2Health News:Back Acne: Tips for Clearer Summer Skin 3Health News:Chief Digital Officer of Travelex joins Bayer, Abellio and Just Eat at The Open Mobile Summit London 2Health News:Technology to Analyze Foot Traffic in Retail Stores was featured on NewsWatch Television 2Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Receives Award at the Spring 2015 Symposium of Advanced Wound Care Conference 2Health News:Vay Technologies Launches uGALE the High Tech Insole Technology for Shoes on KickStarter 2Health News:Vay Technologies Launches uGALE the High Tech Insole Technology for Shoes on KickStarter 3
... the health policy of Britain. Experts arguably explain that as ... hurting it becomes difficult to identify and to be treated ... one in six people at some point of their life ... medical treatment. ,Though this is a condition that ...
... penetrate and destroy viruses due to their protective protein cover ... potent and harmful //. ,Tackling this problem, scientists ... the Outstation of the European Molecular Biology Laboratory (EMBL) in ... structural picture of a protein that allows the rabies virus ...
... people across the globe die every year of ... revealed Friday//. ,The four main diseases influenced ... tract infection, various forms of unintentional injuries and ... "Preventing Disease through Healthy Environments", underlined that over ...
... According to a finding published in the medical journal Pediatrics, ... to guard// against chicken pox spurt in schools. ,Dr. ... Health conducted a study during an outbreak of chicken pox ... the 545 children attending the school had not suffered chicken ...
... Free Hospital in Northwest London where Peter Butler and his ... approval// from the ethics board for going ahead with the ... board had given Butler and his team permission to find ... the risks involved, now it is in the final stage ...
... preventative measures that are urgently needed to stop the ... a healthcare advocate have advised in the latest issue ... is now widely acknowledged as the greatest environmental threat ... the National Centre for Epidemiology and Population Health, ANU. ...
Cached Medicine News:Health News:Depression Could Quickly Grow Into UK’s Biggest Proble 2Health News:13 million environment-linked deaths every year: WHO 2Health News:Doctors Urged to Help Turn Down the Heat 2
... Cannulated Interference Screws. Optimal ... and graft selection options. ... without deformation, and chamfered ... threaded atraumatic tissue fixation. ...
Cannulated Interference Screws...
... mm Mini-TrueView Arthroscopes,Based on the TrueView II ... fibre optic telescopes for small joint arthroscopy ... fully autoclavable and very durable thanks to ... the new telescope class means bright images, ...
Stryker Endoscopy offers a wide variety of small-joint arthroscopes that produce a brilliant high-resolution image without sacrificing Stryker's ultra-high tip durability....
Medicine Products: